Updates in Epilepsy Treatment
Episode 72, Sep 09, 2022, 10:00 AM
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Christopher Elder, MD, clinical assistant professor of neurology, Comprehensive Epilepsy Center, NYU Langone Health. He joined the show to talk about the latest updates in the care of patients with epilepsy, the clinical therapeutic pipeline developments on the horizon, and the need to continue stressing conversations around sudden unexpected death in epilepsy (SUDEP).
Episode Breakdown:
In this episode, we spoke with Christopher Elder, MD, clinical assistant professor of neurology, Comprehensive Epilepsy Center, NYU Langone Health. He joined the show to talk about the latest updates in the care of patients with epilepsy, the clinical therapeutic pipeline developments on the horizon, and the need to continue stressing conversations around sudden unexpected death in epilepsy (SUDEP).
Episode Breakdown:
- 1:15 – The rise of neurostimulation in epilepsy care
- 4:00 – Increasing implantation of minimally invasive options
- 5:15 – Patient reception to nontherapeutic approaches
- 7:45 – The impact of cenobamate (Xcopri; SK Life Science) on the paradigm
- 10:35 – Managing refractory epilepsy
- 12:00 – Upcoming options for those with generalized epilepsy
- 13:50 – Neurology News Minute
- 18:30 – Path forward for gene and cell therapies in epilepsy
- 21:00 – The need to improve early recognition of epilepsy
- 25:20 – Standardizing questionnaires and information for epilepsy
- 27:00 – The need to continue discussing SUDEP
This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.com
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
- FDA Approves Midazolam Autoinjector for Status Epilepticus
- Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
- FDA Lifts Hold on Phase 2 Trial of SRP-5051 in DMD Amenable to Exon 51 Skipping
- Philips Respironics Recalls Masks for BPAP and CPAP Machines After Safety Concerns
- FDA Advisory Committee Votes to Recommend AMX0035 for Treatment of ALS
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.